Literature DB >> 25218899

Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-β in an APP transgenic mouse model.

Fan Liao1, Tony J Zhang2, Thomas E Mahan3, Hong Jiang4, David M Holtzman5.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by impairment of cognitive function, extracellular amyloid plaques, intracellular neurofibrillary tangles, and synaptic and neuronal loss. There is substantial evidence that the aggregation of amyloid β (Aβ) in the brain plays a key role in the pathogenesis of AD and that Aβ aggregation is a concentration dependent process. Recently, it was found that Aβ levels in the brain interstitial fluid (ISF) are regulated by the sleep-wake cycle in both humans and mice; ISF Aβ is higher during wakefulness and lower during sleep. Intracerebroventricular infusion of orexin increased wakefulness and ISF Aβ levels, and chronic sleep deprivation significantly increased Aβ plaque formation in amyloid precursor protein transgenic (APP) mice. Growth hormone-releasing hormone (GHRH) is a well-documented sleep regulatory substance which promotes non-rapid eye movement sleep. GHRHR(lit/lit) mice that lack functional GHRH receptor have shorter sleep duration and longer wakefulness during light periods. The current study was undertaken to determine whether manipulating sleep by interfering with GHRH signaling affects brain ISF Aβ levels in APPswe/PS1ΔE9 (PS1APP) transgenic mice that overexpress mutant forms of APP and PSEN1 that cause autosomal dominant AD. We found that intraperitoneal injection of GHRH at dark onset increased sleep and decreased ISF Aβ and that delivery of a GHRH antagonist via reverse-microdialysis suppressed sleep and increased ISF Aβ. The diurnal fluctuation of ISF Aβ in PS1APP/GHRHR(lit/lit) mice was significantly smaller than that in PS1APP/GHRHR(lit/+) mice. However despite decreased sleep in GHRHR deficient mice, this was not associated with an increase in Aβ accumulation later in life. One of several possibilities for the finding is the fact that GHRHR deficient mice have GHRH-dependent but sleep-independent factors which protect against Aβ deposition.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid-β; Growth hormone–releasing hormone; Sleep

Mesh:

Substances:

Year:  2014        PMID: 25218899      PMCID: PMC4362875          DOI: 10.1016/j.bbi.2014.09.005

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  45 in total

1.  Brain extracellular glucose assessed by voltammetry throughout the rat sleep-wake cycle.

Authors:  L Netchiporouk; N Shram; D Salvert; R Cespuglio
Journal:  Eur J Neurosci       Date:  2001-04       Impact factor: 3.386

2.  Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.

Authors:  J L Varga; A V Schally; V J Csernus; M Zarándi; G Halmos; K Groot; Z Rékási
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  Molecular basis of the little mouse phenotype and implications for cell type-specific growth.

Authors:  S C Lin; C R Lin; I Gukovsky; A J Lusis; P E Sawchenko; M G Rosenfeld
Journal:  Nature       Date:  1993-07-15       Impact factor: 49.962

4.  Proneness to psychological distress and risk of Alzheimer disease in a biracial community.

Authors:  R S Wilson; L L Barnes; D A Bennett; Y Li; J L Bienias; C F Mendes de Leon; D A Evans
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

5.  Intrapreoptic microinjection of GHRH or its antagonist alters sleep in rats.

Authors:  J Zhang; F Obál; T Zheng; J Fang; P Taishi; J M Krueger
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

6.  Sleep deprivation increases rat hypothalamic growth hormone-releasing hormone mRNA.

Authors:  J Zhang; Z Chen; P Taishi; F Obál; J Fang; J M Krueger
Journal:  Am J Physiol       Date:  1998-12

7.  GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function.

Authors:  P Godfrey; J O Rahal; W G Beamer; N G Copeland; N A Jenkins; K E Mayo
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

8.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization.

Authors:  L Pellerin; P J Magistretti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  The effect of REM sleep deprivation on somatostatin and growth hormone-releasing hormone gene expression in the rat hypothalamus.

Authors:  J Toppila; M Asikainen; L Alanko; F W Turek; D Stenberg; T Porkka-Heiskanen
Journal:  J Sleep Res       Date:  1996-06       Impact factor: 3.981

10.  Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.

Authors:  L R Donahue; W G Beamer
Journal:  J Endocrinol       Date:  1993-01       Impact factor: 4.286

View more
  7 in total

Review 1.  Untangling Genetic Risk for Alzheimer's Disease.

Authors:  Anna A Pimenova; Towfique Raj; Alison M Goate
Journal:  Biol Psychiatry       Date:  2017-05-22       Impact factor: 13.382

Review 2.  An important link between the gut microbiota and the circadian rhythm: imply for treatments of circadian rhythm sleep disorder.

Authors:  Yufei Tian; Wei Yang; Gang Chen; Chuanlong Men; Yifan Gu; Xiaoran Song; Ruilin Zhang; Laiyou Wang; Xin Zhang
Journal:  Food Sci Biotechnol       Date:  2022-01-18       Impact factor: 2.391

Review 3.  Growth hormone-releasing hormone receptor signaling in experimental ocular inflammation and neuroprotection.

Authors:  Ling-Ping Cen; Tsz Kin Ng; Wai Kit Chu; Chi Pui Pang
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

4.  The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.

Authors:  Kendra L Puig; Joshua A Kulas; Whitney Franklin; Sharlene G Rakoczy; Giulio Taglialatela; Holly M Brown-Borg; Colin K Combs
Journal:  Neurobiol Aging       Date:  2016-01-06       Impact factor: 4.673

5.  Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model.

Authors:  Fan Liao; Hong Jiang; Subhashini Srivatsan; Qingli Xiao; Katheryn B Lefton; Kaoru Yamada; Thomas E Mahan; Jin-Moo Lee; Andrey S Shaw; David M Holtzman
Journal:  Mol Neurodegener       Date:  2015-03-19       Impact factor: 14.195

6.  Enhanced sleep reverses memory deficits and underlying pathology in Drosophila models of Alzheimer's disease.

Authors:  Stephane Dissel; Markus Klose; Jeff Donlea; Lijuan Cao; Denis English; Raphaelle Winsky-Sommerer; Bruno van Swinderen; Paul J Shaw
Journal:  Neurobiol Sleep Circadian Rhythms       Date:  2016-09-28

7.  Interactions between GHRH and GABAARs in the brains of patients with epilepsy and in animal models of epilepsy.

Authors:  Shirong Tang; Zhong Luo; Xiaowei Qiu; Yanke Zhang; Xi Lu; Hao Huang; Zhongxiang Xu; Zucai Xu
Journal:  Sci Rep       Date:  2017-12-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.